Treating ADHD patients with medication linked to lower risk of death overall, study finds

Medication for ADHD reduces mortality risk, according to Swedish study #

A recent study conducted in Sweden suggests that treating attention-deficit/hyperactivity disorder (ADHD) with medication can help decrease the overall mortality risk for patients. The study tracked nearly 150,000 Swedish residents diagnosed with ADHD between 2007 and 2018. It found that those who received medication had a lower risk of death within two years of diagnosis compared to those who did not receive medication. The report highlights the importance of timely ADHD diagnoses and the need for clinicians to discuss treatment options with patients. Experts also note the ongoing shortage of ADHD medication in the United States, which has been exacerbated since October 2022.